Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

UPDATE 2-Informa's $2.6 bln sale of pharma intelligence lifts shares

Thu, 10th Feb 2022 09:13

(Adds background, analysts' comments)

By Juliette Portala

Feb 10 (Reuters) - Informa agreed to sell its pharma
intelligence business to New York-based investment fund Warburg
Pincus for 1.9 billion pounds ($2.58 billion), the British
events organiser announced on Thursday, sending shares rising by
7%.

The world's largest exhibition group had made plans in
December to divest the entire intelligence unit, which houses
brands such as maritime data provider Lloyd's List and clinical
trial data provider Citeline, while it focuses on its larger
events and academic businesses.

Informa flagged that Pharma Intelligence, which provides
data on clinical trials, drug treatments and medical devices and
accounted for about 40% of its Intelligence unit in 2020, had
drawn "significant" interest over the past two months.

Analysts at Peel Hunt said the sale was at "great price", as
the remaining businesses could approximately yield a further 700
million pounds, well ahead of the brokerage's 2 billion estimate
for the whole division.

Private equity firms have been circling UK-listed companies
since last year, a buyout spree that amounted to $45 billion in
the first half of 2021, Refinitiv data showed.

Informa said it would retain about 15% of Pharma
Intelligence after the deal completion, which is expected by
early June.

After that, it will start divesting the financial
intelligence division, excluding the retail banking joint
venture, Curinos.

Shares rose as much as 7% to their highest level since Nov.
2020 as the group said it planned to return a portion of the
divestment proceeds to shareholders through a share buyback.

The initial tranche of the buyback programme, which starts
immediately and will run through to next June, will be 100
million pounds.

The group also confirmed it expected 2021 earnings in line
with forecasts, set at over 1.8 billion pounds for revenues and
more than 375 million pounds for adjusted operating profit.

Informa predicted that free cash flow would exceed its
previous guidance of above 325 million pounds.
($1 = 0.7378 pounds)
(Reporting by Juliette Portala and Yadarisa Shabong; editing by
Subhranshu Sahu, Shailesh Kuber, Alexandra Hudson)

Related Shares

More News
30 May 2024 13:01

UK dividends calendar - next 7 days

29 May 2024 09:30

LONDON BROKER RATINGS: Berenberg cuts Mobico; RBC raises Fresnillo

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

10 May 2024 09:52

LONDON BROKER RATINGS: UBS raises Trainline, cuts Kingspan

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

9 May 2024 09:53

LONDON BROKER RATINGS: NatWest target raised, other lenders backed

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4% *

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.